Recent studies have explored various aspects of FFAR1 agonists and their potential benefits for T2D patients. One study demonstrated that a specific FFAR1 agonist, compound A, could restore ...

Rosiglitazone acts as a full agonist of PPARγ, a nuclear receptor that induces the transcription and expression of hundreds of genes when activated. Some of these activated genes enhance insulin ...